跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Delstrigo - SFDA Drug Approval Details
Approvals
/
SFDA
/
Delstrigo
Authorized
NCE
Delstrigo
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
4661457734b8d4e7
Company
Unknown
Type
NCE
Approval Details
Approval Id
4661457734b8d4e7
Drug Approval Sfda Name
Delstrigo
Trade Name
Delstrigo
Generic Name
DORAVIRINE,LAMIVUDINE,TENOFOVIR DISOPROXIL
Register Number
1612223019
Register Year
2022
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Tablet Container
Package Size
30
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
do not store above 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
21000004548-645-100000073665
Price
2413.85
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
4661457734b8d4e7
Type
NCE
Back to SFDA Approvals